(Q41454224)

30 September 2017

1 reference

title

Grepafloxacin (English)

1 reference

30 September 2017

Wagstaff AJ

1

1 reference

PubMed ID

9129868

30 September 2017

Balfour JA

series ordinal

2

1 reference

30 September 2017

1 May 1997

1 reference

30 September 2017

1 reference

30 September 2017

53

1 reference

30 September 2017

5

1 reference

30 September 2017

817-24; discussion 825-7

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199753050-00007

30 September 2017

0 references

cites work

Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects

1 reference

12 December 2020

Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829

1 reference

12 December 2020

The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone

1 reference

12 December 2020

Plasma bactericidal activity of a new C-5 methyl fluoroquinolone after oral doses of 400 and 800 mg

1 reference

12 December 2020

Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116))

1 reference

12 December 2020

In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study.

1 reference

12 December 2020

In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.

1 reference

12 December 2020

Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.

1 reference

12 December 2020

Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes

1 reference

12 December 2020

Dissociated resistance among fluoroquinolones

1 reference

12 December 2020

In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents

1 reference

12 December 2020

Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group.

1 reference

12 December 2020

Quinolone antimicrobial agents and theophylline

1 reference

12 December 2020

Clinical experience with OPC-17116 in the treatment of gynaecological infections and its penetration into gynaecological tissues. Japanese Collaborative Study Group of OPC-17116 in Gynaecology

1 reference

12 December 2020

Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin

1 reference

12 December 2020

Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

1 reference

12 December 2020

Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.

1 reference

12 December 2020

In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones

1 reference

12 December 2020

10.2165/00003495-199753050-00007

Identifiers

DOI

1 reference

PubMed ID

9129868

Dimensions Publication ID

30 September 2017

0 references

1 reference

PubMed ID

9129868